The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient Advocacy Award Richard Lane was a long-term heroin user who, upon release…
Read more
AUTHORIZING Patient’s NAME (please print): Last: __________________ First ______________ M.I.___ Date of Birth: ___________________ Social Security #: ______ – _____ – ______ AUTHORIZATION FOR RELEASE OF INFORMATION AND DISCUSSION BETWEEN National Alliance of Methadone Advocates (NAMA) 435 Second Avenue New York, NY 10010 tel/fax: 212 595-6262 AND _____________________________________________ (Person/Facility) ______________________________________________ (Address) ______________________________________________ (Address) ______________________________________________ (City, ST, Zip)…
From NIDDK Fact Sheet Chronic Hepatitis C: Current Disease Management “Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol…
Affiliates Package The first 2 parts of the Affiliates Package are in Ebook format. This means that your computer sees the file as an application and it will have an “exe” file extension. If you click on the file like it is an application – the Ebook with the documents will open. You can then…
National Alliance of Methadone Advocates The President’s Office Joycelyn Woods Executive Report DRAFT New York State Regulations, Page 4 of 5 Go to Page 5
“Together we can make a difference” METHADONE “A life saving medication” Maryland NAMA is the National Alliance of Methadone Advocates (NAMA) official chapter for the state of Maryland. NAMA is a world wide organization dedicated to the betterment of treatment for all methadone patients. Join us in the struggle! NAMA’s Goals To eliminate discrimination toward…
T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…
